ArticleThe Journal of biological chemistry2026
Constitutive activation of a hybrid two-component regulator reveals cross-regulation of polysaccharide utilization genes in Bacteroides.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Human gut microbes, such as Bacteroides, rely on specialized gene clusters known as polysaccharide utilization loci (PULs) to metabolize diverse dietary and host-derived glycans. A major class of transcription regulators of these PULs is the hybrid two-component system (HTCS) containing a histidine sensor kinase and a response regulator within a single transmembrane polypeptide chain. Characterizing HTCS-mediated PUL regulation is often challenging, because the specific glycan signals required to activate most HTCSs remain unknown. Here, we characterized structural details of a highly conserved HTCS activation mechanism and developed a universal activation strategy by mutating the interdomain latch motif that inhibits the DNA-binding activities. Using the response regulator portion of BT4124 from Bacteroides thetaiotaomicron as a model system, crystallographic analyses reveal a "closed" inactive conformation anchored by a hydrogen-bond network formed by the conserved latch residues between the receiver and DNA-binding domains. Molecular dynamic simulation with the deep-learning BioEmu shows that the "AD" mutation of the latch residues destabilizes the inhibitory interface, shifting the conformation equilibrium predominantly to an active, "open" conformation. This constitutively active variant, BT4124R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.